Latest On Agile Therapeutics, Inc (AGRX):
About Agile Therapeutics, Inc (AGRX):
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other transdermal contraceptive products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and AG890, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
General
- Name Agile Therapeutics, Inc
- Symbol AGRX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 28
- Fiscal Year EndDecember
- IPO Date2014-05-23
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.agiletherapeutics.com
Valuation
- Price/Sales (Trailing 12 Mt.) 234.04
- Price/Book (Most Recent Quarter) 3.68
- Enterprise Value Revenue 191.51
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.60
- Next Year EPS Estimate -$0.13
- Next Quarter EPS Estimate -$0.19
- Operating Margin -6549%
- Return on Assets -50%
- Return on Equity -109%
- Revenue 749000
- Earnings Per Share -$0.42
- Revenue Per Share $0.01
- Gross Profit 467000
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 179.64 million
- EBITDA -14902000
- Analyst Target Price $8.25
- Book Value Per Share $0.56
Share Statistics
- Shares Outstanding 87.63 million
- Shares Float 70.92 million
- % Held by Insiders 98%
- % Held by Institutions 49.81%
- Shares Short 2.68 million
- Shares Short Prior Month 2.35 million
- Short Ratio 1.7
- Short % of Float 4%
- Short % of Shares Outstanding 3%
Technicals
- Beta 1.14
- 52 Week High $3.89
- 52 Week Low $1.45
- 50 Day Moving Average 2.81
- 200 Day Moving Average 2.95
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Agile Therapeutics, Inc (AGRX) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Agile Therapeutics, Inc (AGRX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2021-03-01 | $749000 | -$0.20 | -$0.22 | 10.71% |
2020-09-30 | 2020-11-12 | $N/A | -$0.18 | -$0.18 | -1.12% |
2020-06-30 | 2020-08-11 | $N/A | -$0.12 | -$0.14 | 14.29% |
2020-03-31 | 2020-05-05 | $N/A | -$0.10 | -$0.09 | -15.34% |
2019-12-31 | 2020-02-20 | $N/A | -$0.10 | -$0.08 | -33.33% |
2019-09-30 | 2019-10-28 | $N/A | -$0.08 | -$0.08 | 2.08% |
2019-06-30 | 2019-08-01 | $N/A | -$0.08 | -$0.11 | 27.27% |
2019-03-31 | 2019-05-02 | $N/A | -$0.13 | -$0.10 | -36.84% |
2018-12-31 | 2019-03-12 | $N/A | -$0.10 | -$0.16 | 34.19% |
2018-09-30 | 2018-11-01 | $N/A | -$0.11 | -$0.15 | 28.25% |
2018-06-30 | 2018-08-03 | $N/A | -$0.14 | -$0.17 | 12.85% |
2018-03-31 | 2018-05-07 | $N/A | -$0.21 | -$0.20 | -6.06% |
2017-12-31 | 2018-03-12 | $N/A | -$0.18 | -$0.23 | 21.26% |
2017-09-30 | 2017-11-06 | $N/A | -$0.22 | -$0.25 | 12.59% |
2017-06-30 | 2017-07-28 | $N/A | -$0.26 | -$0.28 | 5.8% |
2017-03-31 | 2017-05-08 | $N/A | -$0.26 | -$0.30 | 13.33% |
2016-12-31 | 2017-03-08 | $N/A | -$0.18 | -$0.30 | 40.79% |
2016-09-30 | 2016-11-07 | $N/A | -$0.27 | -$0.34 | 20.59% |
2016-06-30 | 2016-08-08 | $N/A | -$0.29 | -$0.29 | 0.58% |
2016-03-31 | 2016-05-09 | $N/A | -$0.27 | -$0.36 | 25.68% |
2015-12-31 | 2016-03-09 | $N/A | -$0.17 | -$0.45 | 62.22% |
2015-09-30 | 2015-11-09 | $N/A | -$0.42 | -$0.42 | 0% |
2015-06-30 | 2015-08-13 | $N/A | -$0.38 | -$0.37 | -2.7% |
2015-03-31 | 2015-05-12 | $N/A | -$0.40 | -$0.34 | -17.65% |
2014-12-31 | 2015-03-26 | $N/A | -$0.37 | -$0.43 | 13.95% |
2014-09-30 | 2014-11-13 | $N/A | -$0.34 | -$0.50 | 32% |
2014-06-30 | 2014-08-14 | $N/A | -$0.28 | -$0.36 | 22.22% |
2014-03-31 | 2014-05-28 | $N/A | $0.00 |
Agile Therapeutics, Inc (AGRX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Agile Therapeutics, Inc (AGRX) Chart:
Agile Therapeutics, Inc (AGRX) News:
Below you will find a list of latest news for Agile Therapeutics, Inc (AGRX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Agile Therapeutics, Inc (AGRX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest AGRX Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 12:49 PM EST | 38 | $1.27 |
Jun 13, 2022 4:53 PM EST | 2 | $1.14 |
Jun 13, 2022 7:50 PM EST | 11 | $1.14 |
Jun 13, 2022 7:57 PM EST | 100 | $1.14 |
Agile Therapeutics, Inc (AGRX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000155837020007854/0001558370-20-007854-index.htm |
2019-03-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000089924319006367/0000899243-19-006367-index.htm |
2019-10-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000089924319026360/0000899243-19-026360-index.htm |
2019-10-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000089924319026431/0000899243-19-026431-index.htm |
2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm |
2020-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000089924320005836/0000899243-20-005836-index.htm |
2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000089924320008589/0000899243-20-008589-index.htm |
2018-09-25 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1261249/000092963818000765/0000929638-18-000765-index.htm |
2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000101297518000932/0001012975-18-000932-index.htm |
2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1261249/000103738919000003/0001037389-19-000003-index.htm |
2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1261249/000103738920000135/0001037389-20-000135-index.htm |
2018-11-02 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1261249/000104746918007013/0001047469-18-007013-index.htm |
2019-01-23 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1261249/000104746919000195/0001047469-19-000195-index.htm |
2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1261249/000104746919001136/0001047469-19-001136-index.htm |
2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1261249/000104746919002585/0001047469-19-002585-index.htm |
2019-08-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1261249/000104746919004492/0001047469-19-004492-index.htm |
2019-08-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1261249/000104746919004520/0001047469-19-004520-index.htm |
2019-11-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1261249/000104746919006192/0001047469-19-006192-index.htm |
2020-02-20 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1261249/000104746920000966/0001047469-20-000966-index.htm |
2020-02-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1261249/000104746920000969/0001047469-20-000969-index.htm |
2020-02-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1261249/000104746920000994/0001047469-20-000994-index.htm |
2018-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465918049347/0001104659-18-049347-index.htm |
2018-08-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1261249/000110465918049513/0001104659-18-049513-index.htm |
2018-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465918060771/0001104659-18-060771-index.htm |
2018-10-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465918060954/0001104659-18-060954-index.htm |
2018-10-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465918063591/0001104659-18-063591-index.htm |
2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465918065441/0001104659-18-065441-index.htm |
2018-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1261249/000110465918065593/0001104659-18-065593-index.htm |
2018-11-02 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1261249/000110465918065769/0001104659-18-065769-index.htm |
2018-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465918072839/0001104659-18-072839-index.htm |
2019-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919000502/0001104659-19-000502-index.htm |
2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919000994/0001104659-19-000994-index.htm |
2019-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919001481/0001104659-19-001481-index.htm |
2019-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919002849/0001104659-19-002849-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003713/0001104659-19-003713-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003714/0001104659-19-003714-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003715/0001104659-19-003715-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003716/0001104659-19-003716-index.htm |
2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003717/0001104659-19-003717-index.htm |
2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919004817/0001104659-19-004817-index.htm |
2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919004818/0001104659-19-004818-index.htm |
2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919004819/0001104659-19-004819-index.htm |
2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919004820/0001104659-19-004820-index.htm |
2019-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919004821/0001104659-19-004821-index.htm |
2019-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919007141/0001104659-19-007141-index.htm |
2019-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919012545/0001104659-19-012545-index.htm |
2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919014261/0001104659-19-014261-index.htm |
2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919015610/0001104659-19-015610-index.htm |
2019-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919016026/0001104659-19-016026-index.htm |
2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919017469/0001104659-19-017469-index.htm |
2019-04-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919018999/0001104659-19-018999-index.htm |
2019-04-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919019002/0001104659-19-019002-index.htm |
2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919026495/0001104659-19-026495-index.htm |
2019-05-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1261249/000110465919026838/0001104659-19-026838-index.htm |
2019-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919027152/0001104659-19-027152-index.htm |
2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919030128/0001104659-19-030128-index.htm |
2019-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919031110/0001104659-19-031110-index.htm |
2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919034302/0001104659-19-034302-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919034553/0001104659-19-034553-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919034554/0001104659-19-034554-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919034556/0001104659-19-034556-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919034557/0001104659-19-034557-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919034558/0001104659-19-034558-index.htm |
2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919034559/0001104659-19-034559-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919034790/0001104659-19-034790-index.htm |
2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919037213/0001104659-19-037213-index.htm |
2019-06-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919038107/0001104659-19-038107-index.htm |
2019-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919038370/0001104659-19-038370-index.htm |
2019-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919039579/0001104659-19-039579-index.htm |
2019-07-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919039580/0001104659-19-039580-index.htm |
2019-07-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919039872/0001104659-19-039872-index.htm |
2019-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919041329/0001104659-19-041329-index.htm |
2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919043195/0001104659-19-043195-index.htm |
2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1261249/000110465919043196/0001104659-19-043196-index.htm |
2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919043328/0001104659-19-043328-index.htm |
2019-08-02 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1261249/000110465919043736/0001104659-19-043736-index.htm |
2019-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919043744/0001104659-19-043744-index.htm |
2019-08-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919044316/0001104659-19-044316-index.htm |
2019-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465919044317/0001104659-19-044317-index.htm |
2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919044909/0001104659-19-044909-index.htm |
2019-10-28 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1261249/000110465919056670/0001104659-19-056670-index.htm |
2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919056684/0001104659-19-056684-index.htm |
2019-10-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919058371/0001104659-19-058371-index.htm |
2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919061736/0001104659-19-061736-index.htm |
2019-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465919064282/0001104659-19-064282-index.htm |
2020-01-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465920002279/0001104659-20-002279-index.htm |
2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920006857/0001104659-20-006857-index.htm |
2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920006858/0001104659-20-006858-index.htm |
2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920006859/0001104659-20-006859-index.htm |
2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920006860/0001104659-20-006860-index.htm |
2020-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465920017854/0001104659-20-017854-index.htm |
2020-02-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465920022281/0001104659-20-022281-index.htm |
2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465920023400/0001104659-20-023400-index.htm |
2020-02-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465920023929/0001104659-20-023929-index.htm |
2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000110465920025410/0001104659-20-025410-index.htm |
2020-02-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920026463/0001104659-20-026463-index.htm |
2020-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920029907/0001104659-20-029907-index.htm |
2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920034104/0001104659-20-034104-index.htm |
2020-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072478/0001104659-20-072478-index.htm |
2020-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072480/0001104659-20-072480-index.htm |
2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072483/0001104659-20-072483-index.htm |
2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072484/0001104659-20-072484-index.htm |
2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072486/0001104659-20-072486-index.htm |
2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072487/0001104659-20-072487-index.htm |
2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072488/0001104659-20-072488-index.htm |
2020-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072489/0001104659-20-072489-index.htm |
2020-06-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920076109/0001104659-20-076109-index.htm |
2020-08-17 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920096161/0001104659-20-096161-index.htm |
2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920096165/0001104659-20-096165-index.htm |
2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920097236/0001104659-20-097236-index.htm |
2020-08-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920098733/0001104659-20-098733-index.htm |
2020-09-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1261249/000110465920109302/0001104659-20-109302-index.htm |
2020-10-01 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1261249/000110465920111069/0001104659-20-111069-index.htm |
2020-10-02 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920111722/0001104659-20-111722-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1261249/000119312519040984/0001193125-19-040984-index.htm |
2019-03-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1261249/000119312519064818/0001193125-19-064818-index.htm |
2019-10-30 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1261249/000119312519278992/0001193125-19-278992-index.htm |
2019-11-18 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1261249/000119312519294839/0001193125-19-294839-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1261249/000119312520038078/0001193125-20-038078-index.htm |
2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1261249/000121390020003666/0001213900-20-003666-index.htm |
2019-03-14 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1261249/000126124919000001/0001261249-19-000001-index.htm |
2020-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000155837020004156/0001558370-20-004156-index.htm |
2020-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1261249/000155837020004292/0001558370-20-004292-index.htm |
2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000155837020005100/0001558370-20-005100-index.htm |
2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000155837020005192/0001558370-20-005192-index.htm |
2020-05-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1261249/000155837020005210/0001558370-20-005210-index.htm |
2020-06-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000155837020007389/0001558370-20-007389-index.htm |
2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000155837020007854/0001558370-20-007854-index.htm |
2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000155837020010323/0001558370-20-010323-index.htm |
2020-08-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1261249/000155837020010330/0001558370-20-010330-index.htm |
2020-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000155837020010710/0001558370-20-010710-index.htm |
2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1261249/000155837020011221/0001558370-20-011221-index.htm |
2018-11-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1261249/999999999518002891/9999999995-18-002891-index.htm |
2020-10-14 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1261249/999999999520002846/9999999995-20-002846-index.htm |
Agile Therapeutics, Inc (AGRX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agile Therapeutics, Inc (AGRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 98%Institutional Ownership: 4981%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-09-28 | Dennis Reilly | Chief Financial Officer | Buy | 9,000.00 | 2.85 | 25,650.00 | 106,306.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920109302/0001104659-20-109302-index.htm |
2019-08-06 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 2,300,000.00 | 0.95 | 2,185,000.00 | 10,726,750.00 | https://www.sec.gov/Archives/edgar/data/1261249/000089924319026360/0000899243-19-026360-index.htm |
2019-11-15 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 2,000,000.00 | 1.60 | 3,200,000.00 | 11,586,125.00 | https://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm |
2019-11-15 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 333,800.00 | 1.74 | 580,812.00 | 11,919,925.00 | https://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm |
2020-01-22 | Robert G Conway | Sr. VP Manufacturing & Supply | Buy | 6,272.00 | 12,547.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920006857/0001104659-20-006857-index.htm | ||
2020-02-25 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 3,000,000.00 | 3.00 | 9,000,000.00 | 14,919,925.00 | https://www.sec.gov/Archives/edgar/data/1261249/000089924320005836/0000899243-20-005836-index.htm |
2020-03-13 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 1,000,000.00 | 1.75 | 1,750,000.00 | 15,919,925.00 | https://www.sec.gov/Archives/edgar/data/1261249/000089924320008589/0000899243-20-008589-index.htm |
2019-01-24 | ALFRED ALTOMARI | Chief Executive Officer | Buy | 35,314.00 | 213,568.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003713/0001104659-19-003713-index.htm | ||
2019-03-25 | ALFRED ALTOMARI | Chief Executive Officer | Buy | 25,000.00 | 1.54 | 38,500.00 | 238,568.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919017469/0001104659-19-017469-index.htm |
2020-03-04 | Dennis Reilly | Chief Financial Officer | Buy | 25,000.00 | 2.35 | 58,750.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920029907/0001104659-20-029907-index.htm |
2019-06-10 | ALFRED ALTOMARI | Chief Executive Officer | Buy | 20,000.00 | 1.27 | 25,400.00 | 258,568.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919034790/0001104659-19-034790-index.htm |
2020-06-09 | Sandra Carson | Director | Buy | 26,786.00 | 26,786.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072484/0001104659-20-072484-index.htm | ||
2020-06-09 | SHARON BARBARI | Director | Buy | 26,786.00 | 26,786.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072483/0001104659-20-072483-index.htm | ||
2019-01-24 | Geoffrey Gilmore | General Counsel | Buy | 16,480.00 | 28,212.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003714/0001104659-19-003714-index.htm | ||
2020-01-22 | ALFRED ALTOMARI | Chief Executive Officer | Buy | 26,502.00 | 285,070.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920006858/0001104659-20-006858-index.htm | ||
2020-02-27 | ALFRED ALTOMARI | Chief Executive Officer | Buy | 16,541.00 | 0.71 | 11,744.11 | 301,611.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920026463/0001104659-20-026463-index.htm |
2019-01-24 | Elizabeth Garner | Sr. VP & Chief Medical Officer | Buy | 18,565.00 | 30,300.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003716/0001104659-19-003716-index.htm | ||
2019-01-24 | Scott M Coiante | Chief Financial Officer | Buy | 16,070.00 | 30,756.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003715/0001104659-19-003715-index.htm | ||
2020-02-27 | ALFRED ALTOMARI | Chief Executive Officer | Buy | 10,000.00 | 2.71 | 27,100.00 | 311,611.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920026463/0001104659-20-026463-index.htm |
2020-06-09 | James Patrick Tursi | Director | Buy | 13,393.00 | 31,342.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072488/0001104659-20-072488-index.htm | ||
2020-06-09 | John W Hubbard | Director | Buy | 13,393.00 | 31,342.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072486/0001104659-20-072486-index.htm | ||
2020-06-09 | Seth H. Z. Fischer | Director | Buy | 13,393.00 | 31,342.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072489/0001104659-20-072489-index.htm | ||
2018-07-26 | PERCEPTIVE ADVISORS LLC | Insider | Sell | 298,628.00 | 0.30 | 89,439.09 | 3,231,372.00 | https://www.sec.gov/Archives/edgar/data/1261249/000101297518000932/0001012975-18-000932-index.htm |
2020-06-22 | ALFRED ALTOMARI | Chief Executive Officer | Buy | 50,000.00 | 1.76 | 88,000.00 | 361,611.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920076109/0001104659-20-076109-index.htm |
2019-03-29 | Abhijeet J Lele | Director | Buy | 20,000.00 | 1.54 | 30,800.00 | 37,949.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919018999/0001104659-19-018999-index.htm |
2020-06-09 | Ajit Shetty | Director | Buy | 13,393.00 | 38,342.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920072487/0001104659-20-072487-index.htm | ||
2020-08-20 | ALFRED ALTOMARI | Chief Executive Officer | Buy | 94,599.00 | 1.76 | 166,494.24 | 456,210.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920097236/0001104659-20-097236-index.htm |
2019-01-25 | Geoffrey Gilmore | General Counsel | Buy | 17,500.00 | 45,712.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003714/0001104659-19-003714-index.htm | ||
2019-01-25 | Elizabeth Garner | Sr. VP & Chief Medical Officer | Buy | 17,500.00 | 47,800.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003716/0001104659-19-003716-index.htm | ||
2019-01-25 | Scott M Coiante | Chief Financial Officer | Buy | 17,500.00 | 48,256.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003715/0001104659-19-003715-index.htm | ||
2020-01-22 | Geoffrey Gilmore | General Counsel | Buy | 10,071.00 | 55,783.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920006860/0001104659-20-006860-index.htm | ||
2020-03-04 | Dennis Reilly | Chief Financial Officer | Buy | 50,000.00 | 2.32 | 116,000.00 | 59,806.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920029907/0001104659-20-029907-index.htm |
2019-10-29 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Sell | 760,291.00 | 0.44 | 334,528.04 | 6,151,110.00 | https://www.sec.gov/Archives/edgar/data/1261249/000089924319026431/0000899243-19-026431-index.htm |
2019-11-14 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 435,015.00 | 1.69 | 735,175.35 | 6,586,125.00 | https://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm |
2019-10-28 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Sell | 3,815,349.00 | 0.51 | 1,945,827.99 | 6,911,401.00 | https://www.sec.gov/Archives/edgar/data/1261249/000089924319026360/0000899243-19-026360-index.htm |
2020-03-13 | Geoffrey Gilmore | General Counsel | Buy | 25,500.00 | 1.56 | 39,780.00 | 81,283.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920034104/0001104659-20-034104-index.htm |
2019-01-24 | Robert G Conway | SVP Ent Planning & Info Mgt | Buy | 8,625.00 | 8,625.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465919003717/0001104659-19-003717-index.htm | ||
2019-11-15 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 3,000,000.00 | 1.72 | 5,160,000.00 | 9,586,125.00 | https://www.sec.gov/Archives/edgar/data/1261249/000089924319027548/0000899243-19-027548-index.htm |
2020-08-26 | Dennis Reilly | Chief Financial Officer | Buy | 37,500.00 | 1.01 | 37,875.00 | 97,306.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920098733/0001104659-20-098733-index.htm |
2020-01-22 | Dennis Reilly | Chief Financial Officer | Buy | 9,806.00 | 9,806.00 | https://www.sec.gov/Archives/edgar/data/1261249/000110465920006859/0001104659-20-006859-index.htm |